RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Gross profit

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥613.8B
P/E ratio
18.4x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 2025174,939+11.22%
Mar 31, 2024157,285+14.45%
Mar 31, 2023137,421+17.97%
Mar 31, 2022116,488+8.91%
Mar 31, 2021106,960-6.33%
Mar 31, 2020114,192+4.25%
Mar 31, 2019109,533+8.45%
Mar 31, 2018100,996+10.57%
Mar 31, 201791,344-8.44%
Mar 31, 201699,766+10.39%
Mar 31, 201590,379

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)